Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Trade Desk
TTD
|
$869M |
| 2 |
10x Genomics
TXG
|
$712M |
| 3 |
Recursion Pharmaceuticals
RXRX
|
$676M |
| 4 |
Snowflake
SNOW
|
$621M |
| 5 |
OTLY
Oatly Group
OTLY
|
$583M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$1.57B |
| 2 |
Amazon
AMZN
|
$1.49B |
| 3 |
Mastercard
MA
|
$663M |
| 4 |
Ferrari
RACE
|
$384M |
| 5 |
Interactive Brokers
IBKR
|
$300M |
Sector Composition
| 1 | Consumer Discretionary | 29.73% |
| 2 | Healthcare | 22.49% |
| 3 | Technology | 18.75% |
| 4 | Communication Services | 13.22% |
| 5 | Financials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Fortive
FTV
$16.1B
| $7.61M | ﹤0.01% |
109,062
| – | – |
|
252
Relay Therapeutics
RLAY
$690M
| $7.04M | ﹤0.01% |
192,521
+21,235
| +12% | +$777K |
|
|
UXIN
253
Uxin Ltd
UXIN
$730M
| $6.84M | ﹤0.01% |
17,761
| – | – |
|
|
DCBO
254
Docebo
DCBO
$894M
| $6.75M | ﹤0.01% |
113,935
+83,735
| +277% | +$4.96M |
|
255
TJX Companies
TJX
$157B
| $6.42M | ﹤0.01% |
95,163
-36,885
| -28% | -$2.49M |
|
256
Alector
ALEC
$285M
| $6.27M | ﹤0.01% |
300,828
+38,615
| +15% | +$804K |
|
257
American Well
AMWL
$109M
| $5.75M | ﹤0.01% |
22,858
+2,894
| +14% | +$728K |
|
|
KLDO
258
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $4.9M | ﹤0.01% |
658,461
+1,070
| +0.2% | +$7.96K |
|
|
SAGE
259
DELISTED
Sage Therapeutics
SAGE
| $4.56M | ﹤0.01% |
80,265
+10,516
| +15% | +$597K |
|
260
Lyell Immunopharma
LYEL
$225M
| $4.2M | ﹤0.01% |
+12,941
| New | +$4.2M |
|
|
BRW
261
Saba Capital Income & Opportunities Fund
BRW
$353M
| $3.95M | ﹤0.01% |
419,640
| – | – |
|
|
SOHU
262
Sohu.com
SOHU
$487M
| $3.72M | ﹤0.01% |
200,140
| – | – |
|
263
Summit Therapeutics
SMMT
$17.7B
| $3.26M | ﹤0.01% |
436,512
+64,251
| +17% | +$479K |
|
264
Adicet Bio
ACET
$59.4M
| $1.87M | ﹤0.01% |
181,626
| – | – |
|
265
Korea Electric Power
KEP
$17.4B
| $1.77M | ﹤0.01% |
163,646
+3,427
| +2% | +$37K |
|
266
WEC Energy
WEC
$34.6B
| $1.36M | ﹤0.01% |
15,233
| – | – |
|
267
Fortis
FTS
$25B
| $1.35M | ﹤0.01% |
30,457
| – | – |
|
268
Exelon
EXC
$43.8B
| $987K | ﹤0.01% |
31,220
| – | – |
|
269
Newmont
NEM
$82.3B
| $946K | ﹤0.01% |
14,931
+8,421
| +129% | +$534K |
|
|
APRN
270
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $636K | ﹤0.01% |
12,376
| – | – |
|
271
Wheaton Precious Metals
WPM
$46.6B
| $607K | ﹤0.01% |
13,764
+5,599
| +69% | +$247K |
|
272
VYNE Therapeutics
VYNE
$7.91M
| $347K | ﹤0.01% |
5,487
| – | – |
|
|
MBT
273
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $275K | ﹤0.01% |
29,700
| – | – |
|
274
Pan American Silver
PAAS
$12.1B
| $129K | ﹤0.01% |
+4,500
| New | +$129K |
|
275
First Majestic Silver
AG
$4.43B
| $128K | ﹤0.01% |
+8,100
| New | +$128K |
|